MYCELX Technologies Corporation Logo

MYCELX Technologies Corporation

MYX.L

(0.8)
Stock Price

37,50 GBp

-30.67% ROA

-37.43% ROE

-4.03x PER

Market Cap.

11.893.733,53 GBp

8.48% DER

0% Yield

-36.36% NPM

MYCELX Technologies Corporation Stock Analysis

MYCELX Technologies Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

MYCELX Technologies Corporation Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (11%), which means it has a small amount of debt compared to the ownership it holds

2 PBV

The stock's PBV ratio (1.5x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

3 ROE

Negative ROE (-34.03%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-30.97%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (-3), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

MYCELX Technologies Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

MYCELX Technologies Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

MYCELX Technologies Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

MYCELX Technologies Corporation Revenue
Year Revenue Growth
2008 2.672.880
2009 2.562.786 -4.3%
2010 4.302.543 40.44%
2011 6.256.806 31.23%
2012 12.297.000 49.12%
2013 21.379.000 42.48%
2014 13.581.000 -57.42%
2015 13.592.000 0.08%
2016 7.923.000 -71.55%
2017 13.751.000 42.38%
2018 26.952.000 48.98%
2019 11.908.000 -126.34%
2019 11.908.000 0%
2020 7.104.000 -67.62%
2021 8.478.000 16.21%
2022 10.026.000 15.44%
2023 10.678.000 6.11%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

MYCELX Technologies Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2008 253.726
2009 239.301 -6.03%
2010 247.380 3.27%
2011 506.636 51.17%
2012 870.000 41.77%
2013 479.000 -81.63%
2014 443.000 -8.13%
2015 172.000 -157.56%
2016 0 0%
2017 0 0%
2018 0 0%
2019 352.000 100%
2019 352.000 0%
2020 64.000 -450%
2021 223.000 71.3%
2022 218.000 -2.29%
2023 282.000 22.7%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

MYCELX Technologies Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 7.065.000 100%
2013 9.864.000 28.38%
2014 11.473.000 14.02%
2015 9.594.000 -19.59%
2016 6.588.000 -45.63%
2017 7.772.000 15.23%
2018 9.264.000 16.11%
2019 386.000 -2300%
2019 7.754.000 95.02%
2020 0 0%
2021 0 0%
2022 0 0%
2023 6.256.000 100%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

MYCELX Technologies Corporation EBITDA
Year EBITDA Growth
2008 383.506
2009 291.042 -31.77%
2010 468.144 37.83%
2011 -2.422.842 119.32%
2012 -1.188.000 -103.94%
2013 2.348.000 150.6%
2014 -4.114.000 157.07%
2015 -1.583.000 -159.89%
2016 -1.600.000 1.06%
2017 477.000 435.43%
2018 5.597.000 91.48%
2019 -1.150.000 586.7%
2019 -1.137.000 -1.14%
2020 -4.626.000 75.42%
2021 -2.968.000 -55.86%
2022 -2.484.000 -19.48%
2023 -3.182.000 21.94%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

MYCELX Technologies Corporation Gross Profit
Year Gross Profit Growth
2008 1.773.171
2009 1.552.224 -14.23%
2010 2.314.104 32.92%
2011 2.935.695 21.17%
2012 6.560.000 55.25%
2013 12.174.000 46.11%
2014 7.099.000 -71.49%
2015 7.249.000 2.07%
2016 4.103.000 -76.68%
2017 7.466.000 45.04%
2018 14.060.000 46.9%
2019 6.086.000 -131.02%
2019 6.086.000 0%
2020 1.592.000 -282.29%
2021 3.275.000 51.39%
2022 4.442.000 26.27%
2023 2.746.000 -61.76%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

MYCELX Technologies Corporation Net Profit
Year Net Profit Growth
2008 349.968
2009 179.475 -95%
2010 339.756 47.18%
2011 -2.763.190 112.3%
2012 -1.976.000 -39.84%
2013 565.000 449.73%
2014 -5.920.000 109.54%
2015 -3.649.000 -62.24%
2016 -3.279.000 -11.28%
2017 -1.158.000 -183.16%
2018 3.070.000 137.72%
2019 -2.959.000 203.75%
2019 -2.959.000 0%
2020 -6.094.000 51.44%
2021 -1.425.000 -327.65%
2022 -3.991.000 64.29%
2023 -4.402.000 9.34%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

MYCELX Technologies Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

MYCELX Technologies Corporation Free Cashflow
Year Free Cashflow Growth
2008 163.318
2009 127.734 -27.86%
2010 -7.829 1731.55%
2011 -2.794.272 99.72%
2012 -5.902.000 52.66%
2013 -11.044.000 46.56%
2014 -4.455.000 -147.9%
2015 -2.983.000 -49.35%
2016 -89.000 -3251.69%
2017 136.000 165.44%
2018 -217.000 162.67%
2019 -697.250 68.88%
2019 -2.789.000 75%
2020 -1.657.000 -68.32%
2021 -3.796.000 56.35%
2022 -3.528.000 -7.6%
2023 -501.500 -603.49%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

MYCELX Technologies Corporation Operating Cashflow
Year Operating Cashflow Growth
2008 314.971
2009 213.430 -47.58%
2010 198.843 -7.34%
2011 -1.878.907 110.58%
2012 -2.644.000 28.94%
2013 -3.276.000 19.29%
2014 -1.212.000 -170.3%
2015 -2.085.000 41.87%
2016 105.000 2085.71%
2017 194.000 45.88%
2018 298.000 34.9%
2019 -480.500 162.02%
2019 -1.922.000 75%
2020 -1.498.000 -28.3%
2021 -3.426.000 56.28%
2022 -2.686.000 -27.55%
2023 -501.000 -436.13%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

MYCELX Technologies Corporation Capital Expenditure
Year Capital Expenditure Growth
2008 151.653
2009 85.696 -76.97%
2010 206.672 58.54%
2011 915.365 77.42%
2012 3.258.000 71.9%
2013 7.768.000 58.06%
2014 3.243.000 -139.53%
2015 898.000 -261.14%
2016 194.000 -362.89%
2017 58.000 -234.48%
2018 515.000 88.74%
2019 216.750 -137.6%
2019 867.000 75%
2020 159.000 -445.28%
2021 370.000 57.03%
2022 842.000 56.06%
2023 500 -168300%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

MYCELX Technologies Corporation Equity
Year Equity Growth
2008 479.747
2009 810.066 40.78%
2010 1.147.658 29.42%
2011 17.575.316 93.47%
2012 16.453.000 -6.82%
2013 19.048.000 13.62%
2014 25.024.000 23.88%
2015 21.997.000 -13.76%
2016 18.841.000 -16.75%
2017 17.815.000 -5.76%
2018 20.973.000 15.06%
2019 19.844.000 -5.69%
2020 13.792.000 -43.88%
2021 12.622.000 -9.27%
2022 10.832.000 -16.53%
2023 7.157.000 -51.35%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

MYCELX Technologies Corporation Assets
Year Assets Growth
2008 1.383.831
2009 1.422.872 2.74%
2010 2.224.859 36.05%
2011 19.127.862 88.37%
2012 19.481.000 1.81%
2013 27.595.000 29.4%
2014 33.330.000 17.21%
2015 25.297.000 -31.75%
2016 22.365.000 -13.11%
2017 21.494.000 -4.05%
2018 27.938.000 23.07%
2019 24.502.000 -14.02%
2020 19.132.000 -28.07%
2021 15.658.000 -22.19%
2022 13.619.000 -14.97%
2023 10.390.000 -31.08%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

MYCELX Technologies Corporation Liabilities
Year Liabilities Growth
2008 904.084
2009 612.805 -47.53%
2010 1.077.201 43.11%
2011 1.552.545 30.62%
2012 3.028.000 48.73%
2013 8.547.000 64.57%
2014 8.306.000 -2.9%
2015 3.300.000 -151.7%
2016 3.524.000 6.36%
2017 3.679.000 4.21%
2018 6.965.000 47.18%
2019 4.658.000 -49.53%
2020 5.340.000 12.77%
2021 3.036.000 -75.89%
2022 2.787.000 -8.93%
2023 3.233.000 13.8%

MYCELX Technologies Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.35
Net Income per Share
-0.13
Price to Earning Ratio
-4.03x
Price To Sales Ratio
1.46x
POCF Ratio
-11.24
PFCF Ratio
-10.77
Price to Book Ratio
1.66
EV to Sales
1.49
EV Over EBITDA
-5.98
EV to Operating CashFlow
-11.45
EV to FreeCashFlow
-10.98
Earnings Yield
-0.25
FreeCashFlow Yield
-0.09
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.95
Graham NetNet
0.02

Income Statement Metrics

Net Income per Share
-0.13
Income Quality
0.36
ROE
-0.37
Return On Assets
-0.28
Return On Capital Employed
-0.34
Net Income per EBT
1.1
EBT Per Ebit
1
Ebit per Revenue
-0.33
Effective Tax Rate
-0.1

Margins

Sales, General, & Administrative to Revenue
0.61
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.32
Operating Profit Margin
-0.33
Pretax Profit Margin
-0.33
Net Profit Margin
-0.36

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.05
Free CashFlow per Share
-0.05
Capex to Operating CashFlow
-0.04
Capex to Revenue
0.01
Capex to Depreciation
0.07
Return on Invested Capital
-0.38
Return on Tangible Assets
-0.31
Days Sales Outstanding
92.88
Days Payables Outstanding
102.42
Days of Inventory on Hand
227.12
Receivables Turnover
3.93
Payables Turnover
3.56
Inventory Turnover
1.61
Capex per Share
0

Balance Sheet

Cash per Share
0,02
Book Value per Share
0,31
Tangible Book Value per Share
0.28
Shareholders Equity per Share
0.31
Interest Debt per Share
0.03
Debt to Equity
0.08
Debt to Assets
0.06
Net Debt to EBITDA
-0.11
Current Ratio
2.36
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
7764000
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.07
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
3417000
Debt to Market Cap
0.05

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

MYCELX Technologies Corporation Dividends
Year Dividends Growth

MYCELX Technologies Corporation Profile

About MYCELX Technologies Corporation

MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the oil and gas, power, marine, and heavy manufacturing sectors in the Middle East, the United States, Nigeria, Australia and internationally. The company offers oil removal solutions for upstream produced water to oil companies; and hydrocarbons removal services from downstream process wastewater that are used in petrochemical facilities and refineries. It also sells or leases its equipment; and sells consumable filtration media. MYCELX Technologies Corporation was incorporated in 1994 and is headquartered in Norcross, Georgia.

CEO
Ms. Connie Mixon
Employee
18
Address
1650 International Court
Norcross, 30093

MYCELX Technologies Corporation Executives & BODs

MYCELX Technologies Corporation Executives & BODs
# Name Age
1 Ms. Kimberly Slayton
Chief Financial Officer & Secretary
70
2 Mr. Haluk Alper
Co-Founder, President, Chief Science Officer & Executive Director
70
3 Ms. Connie Mixon
Chief Executive Officer & Executive Director
70
4 Mr. John Mansfield Sr.
Co-Founder & Chairman Emeritus
70

MYCELX Technologies Corporation Competitors

Microsaic Systems plc Logo
Microsaic Systems plc

MSYS.L

(1.0)
Serinus Energy plc Logo
Serinus Energy plc

SENX.L

(1.0)
Getech Group plc Logo
Getech Group plc

GTC.L

(1.0)